DLHCX
Price
$19.73
Change
+$0.17 (+0.87%)
Updated
Apr 17 closing price
Net Assets
646.86M
JFNIX
Price
$64.83
Change
+$0.02 (+0.03%)
Updated
Apr 17 closing price
Net Assets
4.71B
Ad is loading...

DLHCX vs JFNIX

Header iconDLHCX vs JFNIX Comparison
Open Charts DLHCX vs JFNIXBanner chart's image
Macquarie Healthcare C
Price$19.73
Change+$0.17 (+0.87%)
VolumeN/A
Net Assets646.86M
Janus Henderson Global Life Sciences I
Price$64.83
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets4.71B
DLHCX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHCX vs. JFNIX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Hold and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.71B vs. DLHCX (647M). JFNIX pays higher dividends than DLHCX: JFNIX (0.39) vs DLHCX (0.00). DLHCX was incepted earlier than JFNIX: DLHCX (15 years) vs JFNIX (16 years). DLHCX (2.00) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. DLHCX (5.00). DLHCX has a lower initial minimum investment than JFNIX: DLHCX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -7.78 vs. DLHCX (-15.32). JFNIX return over 5 years is better than : 12.94 vs. DLHCX (-17.76).
DLHCXJFNIXDLHCX / JFNIX
Total Expense Ratio1.960.77255%
Annual Report Gross Expense Ratio2.000.77260%
Fund Existence15 years16 years-
Gain YTD-5.958-4.690127%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets647M4.71B14%
Annual Yield % from dividends0.000.39-
Returns for 1 year-15.32-7.78197%
Returns for 3 years-22.87-0.703,282%
Returns for 5 years-17.7612.94-137%
Returns for 10 years-0.899.62-9%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNVAX41.53N/A
N/A
Putnam International Capital Opp A
LVAGX13.90N/A
N/A
LSV Global Value Investor
NBHEX13.53N/A
N/A
Neuberger Berman Equity Income E
JLPYX18.96-0.06
-0.32%
JPMorgan US Large Cap Core Plus R6
RNGEX53.92-0.23
-0.42%
American Funds New Economy R4